What sets the FLH Life Sciences Practice apart is our multidisciplinary, integrated approach to address legal issues and business challenges involved in maximizing the value of intellectual property. Whether our involvement begins with protecting an idea, papering a deal, or defending a patent in litigation, the FLH expertise in the Life Sciences is able to efficiently handle our clients’ needs. Our size, structure, and technical capabilities allow us to seamlessly integrate our specialties, affording our clients a unique opportunity to create, expand, and protect their intellectual property through a unified approach. FLH merges areas of traditional intellectual property practice with transactional, regulatory, and antitrust law, providing comprehensive legal solutions for our clients in the Life Sciences.
Capturing ideas and transforming them into tangible assets is just one of the many Life Sciences initiatives our attorneys, patent agents, and scientific advisors handle every day. FLH prepares and prosecutes patent applications in the most progressive areas of numerous technologies, including molecular biology, cellular biology, transgenic animals, virology, immunology, genomics, proteomics, and biomarkers. The products protected by the patents we prosecute include pharmaceuticals, biologics, diagnostics, and medical devices. We successfully prosecute patent applications for research institutions, universities, corporations, and growth enterprises and manage the intellectual property issues that are unique to each of them. Our proven expertise in obtaining patents through the accelerated examination procedure before the USPTO offers our clients the potential to more expeditiously manage the issuance of their patents.
The management of Life Sciences intellectual property rights does not rest solely within the realm of patent prosecution. Our patent attorneys and litigators often collaborate to cultivate an innovative strategy that ultimately produces the strongest possible patent rights for our clients. This collaboration is possible, in part, because Life Sciences litigation at FLH has a diverse approach to its practice. Since its inception almost 15 years ago, FLH has been a leader in representing clients involved in all types of pharmaceutical patent litigation, from small molecules to biologics to diagnostics. Litigation at the firm has evolved with its representation of clients in breach of contract disputes, some involving ownership of intellectual property and others concerning the supply of an exclusive product. The breadth of our litigation expertise in the areas of patent infringement, validity and enforceability, complemented by our experience in handling contractual disputes, enables FLH to provide its Life Sciences clients with a multi-prong approach when it comes to protecting their intellectual property.
Patent prosecution and litigation are often viewed as traditional intellectual property practices that are at opposite ends of the life cycle spectrum. But there are various other legal and business approaches that can be taken to enhance the value of intellectual property. FLH has seized on these opportunities through the creation of its transactional, antitrust, and regulatory practices. Our transactional attorneys negotiate and prepare all types of agreements in the Life Sciences, from customized nondisclosure/confidentiality agreements, to complex licenses, to nuanced settlements, all the way to product acquisitions. FLH facilitates the in-licensing and out-licensing of intellectual property rights to help our academic clients protect and develop the next generation of leading edge innovations. Frequently the negotiation and completion of complex deals includes sophisticated counseling by the FLH antitrust practice, which is efficiently done through cooperation with the FLH patent attorneys and litigators.
FLH has proven expertise in delivering the highest level of service to clients while guiding them through the entire life cycle of their products. We are conscious that not every client is the same. We align product and patent life cycle strategies with the timelines, business objectives, and resources of our clients. Whether it is creating start-up portfolios, revamping patent strategies, or maintaining long-term targets, we tailor our practice to meet the individual needs of each of our clients. We invite you to consider how our distinct approach to the law and Life Sciences can help you maximize the potential of your intellectual property.